Saturday 7 November 2026 Export AGIO’s income statement to Excel — free account

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $54.0 million, up 48.0% from fiscal 2024.

Revenue: +330.0%
EPS: +38.8%
Free cash flow: +32.6%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

29.41 1.14 +4.03%

Follow AGIO

Alert me

Market cap: $1.7B
P/E: 0.0×
Fwd P/E: −5.1×
Dividend yield: —
F-score: 3/9
Altman Z: 8.12
Beneish M: −1.72
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		29.21	30.11	22.45	14.10
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(16.40)	(16.72)	(38.52)	(33.51)
P/B ratio Full definition →		1.32	1.79	2.15	2.03
Price to Tangible BV Full definition →		1.32	1.79	2.15	2.03
EV/Sales Full definition →		13.40	18.95	16.17	9.62
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(1.94)	(3.29)	(4.41)	(4.09)
EV/FCF Full definition →		(1.92)	(3.25)	(4.35)	(4.03)
Quick Ratio Full definition →		10.52	12.80	9.08	8.12
Current Ratio Full definition →		11.46	14.19	10.22	9.69
Net Debt/EBITDA Full definition →		7.00	6.71	5.60	8.22
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.04	0.05	0.08	0.12
Operating CF/Net income Full definition →		0.89	1.20	0.57	0.91
Capex/Depreciation Full definition →		2.30	(3.51)	(5.43)	(2.23)
Research and Development Expense of Revenue Full definition →		441.01%	391.15%	225.17%	132.68%
Selling, General and Administrative Expense of Revenue Full definition →		258.48%	232.84%	115.20%	102.07%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		70.74%	74.91%	35.63%	30.10%
Graham Net Nets Full definition →		0.53	0.38	0.29	0.34
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(26.12%)	(21.43%)	(18.89%)	(19.01%)
Free Cash Flow Yield Full definition →		(23.91%)	(19.35%)	(16.54%)	(16.92%)
Revenue per Share Full definition →		0.34	0.35	0.75	0.93
Operating CF per Share Full definition →		(1.66)	(2.02)	(0.96)	(0.99)
Capex per Share Full definition →		(0.02)	(0.01)	(0.02)	(0.02)
Free Cash Flow per Share Full definition →		(1.68)	(2.04)	(0.98)	(1.01)
Cash per Share Full definition →		14.74	12.54	10.38	10.55
Shareholders Equity per Share Full definition →		20.58	18.87	17.25	16.40
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		20.58	18.87	17.25	16.40
Free Cash Flow Full definition →		(97.33)	(119.69)	(58.52)	(60.42)
Working Capital Full definition →		859.85	776.00	647.45	674.51
Capital Expenditures Full definition →		(1.12)	(0.77)	(1.21)	(1.18)
Net Current Asset Value Full definition →		837.94	758.97	635.27	667.39
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.06	0.04	0.03	0.02
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		7.34	9.74	12.55	—
Average Payables Full definition →		17.50	13.74	16.94	19.74
Average Inventory Full definition →		30.27	32.35	30.50	—
Average Assets Full definition →		1,480.21	1,370.25	1,289.83	1,224.87
Average Common Equity Full definition →		1,367.04	1,287.82	1,197.79	1,131.83

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly